期刊文献+

Relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma 被引量:5

Relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma
下载PDF
导出
摘要 Objective:To study the relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma.Methods:A total of 297 patients from July 2009 to May 2013 were chosen as objects.EGFR gene mutation were detected with fluorescence quantitative PCR.Relevance of EGFR gene mutation with clinical and pathological features was analyzed,and the prognosis of EGFR- mutant-patients and that of EGFR- wide type-patients was compared.Results:In 297 patients.136(45.79%) showed EGFR gene mutation.EGFR gene mutation had no significant relevance with age.gender,smoking history,family history of cancer and clinical stage(P>0.05);there was significant relevance between EGFR gene mutation and blood type,pathologic types,differentiation and diameter of cancer(P<0.05).The difference between prognosis of EGFR- mutant-patients and that of EGFR- wide type-patients was statistical significance(P<0.05).Conclusions:EGFR gene mutation has significant relevance with pathological features,the prognosis of EGFRmutant-paticnts is better than that of EGFR- wide type-patients. Objective:To study the relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma.Methods:A total of 297 patients from July 2009 to May 2013 were chosen as objects.EGFR gene mutation were detected with fluorescence quantitative PCR.Relevance of EGFR gene mutation with clinical and pathological features was analyzed,and the prognosis of EGFR- mutant-patients and that of EGFR- wide type-patients was compared.Results:In 297 patients.136(45.79%) showed EGFR gene mutation.EGFR gene mutation had no significant relevance with age.gender,smoking history,family history of cancer and clinical stage(P&gt;0.05);there was significant relevance between EGFR gene mutation and blood type,pathologic types,differentiation and diameter of cancer(P&lt;0.05).The difference between prognosis of EGFR- mutant-patients and that of EGFR- wide type-patients was statistical significance(P&lt;0.05).Conclusions:EGFR gene mutation has significant relevance with pathological features,the prognosis of EGFRmutant-paticnts is better than that of EGFR- wide type-patients.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第3期249-252,共4页 亚太热带医药杂志(英文版)
基金 supported by Project Development Plan of Yantai city Science and Technology(No.2013WS229)
关键词 EPIDERMAL growth factor receptor Non-small-cell LUNG carcinoma Fluorescence quantitative PCR PATHOLOGICAL features PROGNOSIS Epidermal growth factor receptor Non-small-cell lung carcinoma Fluorescence quantitative PCR Pathological features Prognosis
  • 相关文献

参考文献7

二级参考文献110

  • 1张晓彤,李龙芸,王树兰,穆新林,王孟昭.吉非替尼治疗晚期非小细胞肺癌疗效观察[J].中华结核和呼吸杂志,2005,28(3):180-183. 被引量:31
  • 2管忠震,张力,李龙芸,蒋国梁,刘叙仪,储大同,赵洪云,李玮.吉非替尼治疗局部晚期或转移性非小细胞肺癌在中国的临床研究[J].癌症,2005,24(8):980-984. 被引量:114
  • 3徐美林,刘岩,钟镐镐,吴秉铨.非小细胞肺癌表皮生长因子受体突变的检测及临床病理意义[J].中华病理学杂志,2007,36(7):453-456. 被引量:9
  • 4Voldborg BR, Damstrup L, Spang-Thomsen M, et al. Epidermal growth factor receptor(EGFR) and EGFR mutations, function and possible role in clinical trials [ J ]. Annals of Oncology, 1997,8 (12) :1197-1206.
  • 5Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors[ J]. Nat Rev Cancer,2005,5 (5) :341-354.
  • 6Citri A, Yarden Y. EGF-ERBB signaling: towards the systems level[ J ]. Nat Rev Mol Cell Biol,2006,7 (7) :505-516.
  • 7Alaoui-Jamali MA, Qiang H. The interface between ErbBand and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery [ J ]. Drug Resist Updat,2003,6 (2) :95-107.
  • 8Bianco R, Gelardi T, Damiano V, et al. Mechanisms of resistance to EGFR inhibitors[ J]. Targ Oncol,2007,2:31-37.
  • 9Salomon DS, Brandt R, Ciardiello F, et al. Epidermal growth factor-related peptides and their receptors in human malignancies[ J]. Crit Rev Oncol Hematol, 1995,19 (3) :183-132.
  • 10Bencardino K, Manzoni M, Delfanti S, et al. Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of nonsmall-cell lung cancer: results and open issues [ J ]. Inter Emerg Med,2007,2( 1 ) :3-12.

共引文献136

同被引文献9

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部